Monograph Details
|
|
Pain & Pyrexia
> Migraine and headache
|
|
FIORICET w. CODEINE |
| Manufacturer |
|
Watson Pharmaceuticals, Inc. |
| Legal Classification |
|
CIII |
| Pharmacological Class |
|
Opioid + barbiturate + analgesic. |
| Generic Name |
|
Codeine phosphate 30mg, butalbital 50mg, acetaminophen 325mg, caffeine 40mg; caps. |
| Also |
|
• FIORICET
|
| Indications |
|
Tension (or muscle contraction) headache. |
| Children |
|
Not recommended. |
| Adults |
|
1–2 tabs or caps every 4 hours as needed; max 6/day. |
| Contraindications |
|
Porphyria. |
| Precautions |
|
Drug abusers. Impaired hepatic or renal function. Acute abdomen. Depression. Suicidal tendencies. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers: not recommended. For Codeine: Head injury. Increased intracranial pressure. Impaired thyroid or adrenocortical function. GI stricture or urinary obstruction. Labor and delivery. |
| Interactions |
|
Potentiation with alcohol, CNS depressants, general anesthetics, MAOIs. Induction of drug-metabolizing hepatic enzymes. May cause false (+) urine test for 5-hydroxyindoleacetic acid. |
| Adverse Reactions |
|
Drowsiness, dizziness, sedation, shortness of breath, GI disturbances, abdominal pain, depression, confusion, paradoxical excitement, constipation, abuse potential, skin reactions; overdosage: respiratory depression, hepatotoxicity. |
| How Supplied |
Tabs—100, 500
Caps—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
